Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6526
RCM Technologies
RCMT
$294M
| – | – |
-900
| Closed | -$6K | – |
|
6527
Reading International Class B
RDIB
$296M
| $0 | ﹤0.01% |
4
+1
| +33% | +$14 |
2014 Q1
5 quarters
|
|
6528
DELISTED
Baijiayun Group
RTC
| $0 | ﹤0.01% |
1
| – | – |
2014 Q1
5 quarters
|
|
|
SCNI
6529
Scinai Immunotherapeutics
SCNI
$800K
| – | – |
0
| – | – |
2015 Q2
0 quarters
|
|
6530
SCYNEXIS
SCYX
$40.6M
| – | – |
0
| – | – |
2015 Q2
0 quarters
|
|
6531
Origin Agritech
SEED
$8.49M
| $0 | ﹤0.01% |
9
| – | – |
2013 Q4
6 quarters
|
|
6532
Sound Financial Bancorp
SFBC
$109M
| $0 | ﹤0.01% |
5
+1
| +25% | +$20 |
2014 Q1
5 quarters
|
|
6533
Singularity Future Technology
SGLY
$3.89M
| – | – |
-11
| Closed | -$11.5K | – |
|
6534
DELISTED
SPAR Group
SGRP
| $0 | ﹤0.01% |
325
-4
| -1% | -$5 |
2014 Q1
5 quarters
|
|
6535
Seanergy Maritime Holdings
SHIP
$371M
| – | – |
0
| – | – |
2014 Q1
5 quarters
|
|
6536
Siebert Financial
SIEB
$93.2M
| $0 | ﹤0.01% |
38
+1
| +3% | +$2 |
2014 Q1
5 quarters
|
|
6537
Stabilis Solutions
SLNG
$101M
| $0 | ﹤0.01% |
+2
| New | +$85 |
2015 Q2
0 quarters
|
|
6538
DELISTED
Soleno Therapeutics
SLNO
| – | – |
0
| – | – |
2014 Q4
2 quarters
|
|
6539
Southern Missouri Bancorp
SMBC
$770M
| $0 | ﹤0.01% |
14
-158
| -92% | -$3.01K |
2013 Q4
6 quarters
|
|
6540
DELISTED
Semler Scientific
SMLR
| $0 | ﹤0.01% |
9
+1
| +13% | +$4 |
2014 Q1
5 quarters
|
|
6541
Summit Therapeutics
SMMT
$14B
| $0 | ﹤0.01% |
+8
| New | +$91 |
2015 Q2
0 quarters
|
|
6542
The ONE Group
STKS
$47.5M
| $0 | ﹤0.01% |
+1
| New | +$5 |
2015 Q2
0 quarters
|
|
6543
Savara
SVRA
$1.01B
| $0 | ﹤0.01% |
10
| – | – |
2013 Q2
8 quarters
|
|
6544
Transact Technologies
TACT
$46.4M
| $0 | ﹤0.01% |
15
-6,220
| -100% | -$38.6K |
2013 Q3
7 quarters
|
|
6545
DELISTED
Taitron Components
TAIT
| $0 | ﹤0.01% |
8
| – | – |
2014 Q1
5 quarters
|
|
6546
Tandy Leather Factory
TLF
$20.4M
| $0 | ﹤0.01% |
18
+1
| +6% | +$9 |
2013 Q4
6 quarters
|
|
6547
Transcat
TRNS
$807M
| $0 | ﹤0.01% |
13
+1
| +8% | +$10 |
2013 Q4
6 quarters
|
|
6548
TRX Gold Corp
TRX
$383M
| $0 | ﹤0.01% |
765
-50
| -6% | -$17 |
2013 Q2
8 quarters
|
|
6549
AgEagle Aerial Systems
UAVS
$50.9M
| – | – |
0
| – | – |
2015 Q1
1 quarter
|
|
6550
United Bancorp
UBCP
$84.1M
| $0 | ﹤0.01% |
10
+1
| +11% | +$8 |
2014 Q1
5 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.